PROC (Vitamin K-dependent protein C) variants and mutations
PROC (also known as Vitamin K-dependent protein C) is a human protein-coding gene encoding a vitamin K-dependent protein C protein. Its annotated function is protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids. Exerts a protective effect on the endothelial cell barrier function. It is annotated at the endoplasmic reticulum. This analysis covers 653 PROC variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes protein c deficiency, venous thromboembolism, and deep vein thrombosis. Example PROC variants include M1?, W2*, and Q3P.
Variant analysis overview
- Gene: PROC
- Protein: Vitamin K-dependent protein C
- UniProt accession: E7END6
- Organism: Homo sapiens
- Variants analyzed: 653
- Variant scope: all variants
- Completed: 2026-11-09
Variant and mutation evidence
- Variant composition: 238 unspecified-consequence records; 14 stop-gained variants; 86 synonymous variants; 261 missense variants; 33 frameshift variants; 7 splice-region variants; 4 in-frame deletions; 1 protein altering variant; 2 in-frame insertions; 8 substitution
- Prediction scores: 515 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: protein c deficiency, venous thromboembolism, deep vein thrombosis, thrombophilia due to protein C deficiency, autosomal dominant, thrombophilia due to protein C deficiency, autosomal recessive, Abnormal thrombosis, phlebitis, Thrombophlebitis, thrombophilia, blood coagulation disease, Thromboembolism, pulmonary embolism.
Protein structure and variant hotspots
- Protein features: 3 domains.
- Structural context: 355 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, Open Targets, MaveDB, dbNSFP, LitVar.
Diseases linked to PROC
Notable PROC variants
Examples include M1?, W2*, Q3P, Q3*, Q3Q, L4L, T5S, T5R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV9930, cosmic curated COSV99300, Variant assessed as somatic; high impact.
- W2* (p.Trp2Ter), rs2468318751, ClinGen CA348397267, ClinVar RCV003496095, Pathogenic
- Q3P (p.Gln3Pro), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52167, Variant assessed as somatic; moderate impact.
- Q3* (p.Gln3Ter), gnomAD 2-127419949-C-T, CADD 37.00
- Q3Q (p.Gln3Gln), gnomAD 2-127419951-G-A, CADD 3.00
- L4L (p.Leu4Leu), rs750696079, gnomAD 2-127419954-C-T, CADD 3.47
- T5S (p.Thr5Ser), cosmic curated COSV52168
- T5R (p.Thr5Arg), rs759805372, gnomAD 2-127419956-C-G, REVEL 0.42, AlphaMissense 0.21
- S6S (p.Ser6Ser), gnomAD 2-127419960-C-T, CADD 7.70
- L7P (p.Leu7Pro), rs2468318825, ClinGen CA348397343, ClinVar RCV003496651, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- L7L (p.Leu7Leu), gnomAD 2-127419963-C-T, CADD 5.54
- L8A (p.Leu8Ala), rs1375703057, gnomAD 2-127419963-CCT-C, CADD 23.10
- L8L (p.Leu8Leu), gnomAD 2-127419966-G-C, CADD 3.21
- L9L (p.Leu9Leu), gnomAD 2-127419967-C-T, CADD 10.10
- F10L (p.Phe10Leu), cosmic curated COSV52169
- F10F (p.Phe10Phe), rs148490199, gnomAD 2-127419972-C-T, CADD 7.74
- V11L (p.Val11Leu), cosmic curated COSV99300
- V11M (p.Val11Met), rs368493458, gnomAD 2-127419973-G-A, REVEL 0.27, AlphaMissense 0.12
- V11E (p.Val11Glu), gnomAD 2-127419974-T-A, REVEL 0.53, AlphaMissense 0.44
- A12A (p.Ala12Ala), gnomAD 2-127419978-C-A, CADD 9.19
- T13P (p.Thr13Pro), rs781386476, gnomAD 2-127419979-A-C, REVEL 0.52, AlphaMissense 0.12
- T13T (p.Thr13Thr), rs748548752, gnomAD 2-127419981-C-T, CADD 9.16
- W14* (p.Trp14Ter), rs758576042, gnomAD 2-127419983-G-A, CADD 36.00
- G15R (p.Gly15Arg), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52166, Variant assessed as somatic; moderate impact.
- G15E (p.Gly15Glu), gnomAD 2-127419986-G-A, REVEL 0.36, AlphaMissense 0.21
- G15G (p.Gly15Gly), gnomAD 2-127419987-A-C, CADD 6.70
- S17S (p.Ser17Ser), rs770171684, gnomAD 2-127419993-C-T, CADD 9.24
- G18S (p.Gly18Ser), cosmic curated COSV10509, 1000Genomes rs146793243, ESP rs146793243, ExAC rs146793243, REVEL 0.54, AlphaMissense 0.08, Uncertain significance, PROC-related disorder; Thrombophilia due to protein C deficiency, autosomal rece
- G18C (p.Gly18Cys), rs146793243, gnomAD 2-127419994-G-T, REVEL 0.43, AlphaMissense 0.10
- T19T (p.Thr19Thr), gnomAD 2-127419999-A-G, CADD 6.07
- P20S (p.Pro20Ser), gnomAD 2-127420000-C-T, REVEL 0.20, AlphaMissense 0.09
- P20P (p.Pro20Pro), rs1282935697, gnomAD 2-127420002-A-G, CADD 2.60
- P22T (p.Pro22Thr), cosmic curated COSV52164
- P22A (p.Pro22Ala), rs771569764, gnomAD 2-127420006-C-G, REVEL 0.27, AlphaMissense 0.07
- P22L (p.Pro22Leu), rs775126434, gnomAD 2-127420007-C-T, REVEL 0.29, AlphaMissense 0.10
- P22P (p.Pro22Pro), rs144300387, gnomAD 2-127420008-T-C, CADD 6.99
- L23F (p.Leu23Phe), cosmic curated COSV10634
- L23L (p.Leu23Leu), gnomAD 2-127420011-T-C, CADD 0.01
- D24V (p.Asp24Val), gnomAD 2-127421283-A-T, REVEL 0.57, AlphaMissense 0.19
- D24G (p.Asp24Gly), rs1455533451, gnomAD 2-127421283-A-G, REVEL 0.31, AlphaMissense 0.11
- D24D (p.Asp24Asp), rs764423112, gnomAD 2-127421284-C-T, CADD 13.80
- S25S (p.Ser25Ser), rs1214393595, gnomAD 2-127421287-A-G, CADD 10.10
- V26M (p.Val26Met), rs754243426, gnomAD 2-127421288-G-A, REVEL 0.87, AlphaMissense 0.34
- F27L (p.Phe27Leu), gnomAD 2-127421286-CAG-C, CADD 33.00
- S28S (p.Ser28Ser), rs889074002, gnomAD 2-127421296-C-G, CADD 10.60
- S29G (p.Ser29Gly), rs1433394075, gnomAD 2-127421297-A-G, REVEL 0.46, AlphaMissense 0.12
- S30N (p.Ser30Asn), gnomAD 2-127421301-G-A, REVEL 0.36, AlphaMissense 0.25
- S30S (p.Ser30Ser), rs552714462, gnomAD 2-127421302-C-T, CADD 6.26
- S30R (p.Ser30Arg), rs552714462, gnomAD 2-127421302-C-A, REVEL 0.32, AlphaMissense 0.35
- E31V (p.Glu31Val), rs2468324840, ClinGen CA348397686, ClinVar RCV002776555, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- E31P (p.Glu31Pro), gnomAD 2-127421300-AGCGA, CADD 25.00
- E31* (p.Glu31Ter), gnomAD 2-127421303-G-T, CADD 35.00
- E31K (p.Glu31Lys), rs779710709, gnomAD 2-127421303-G-A, REVEL 0.29, AlphaMissense 0.08
- R32C (p.Arg32Cys), rs2468324848, ClinGen CA348397690, ClinVar RCV002776556, REVEL 0.60, AlphaMissense 0.28, Pathogenic, Thrombophilia due to protein C deficiency, autosomal dominant
- R32S (p.Arg32Ser), cosmic curated COSV52166, REVEL 0.27, AlphaMissense 0.22
- R32L (p.Arg32Leu), gnomAD 2-127421307-G-T, REVEL 0.42, AlphaMissense 0.15
- R32H (p.Arg32His), rs746654539, gnomAD 2-127421307-G-A, REVEL 0.28, AlphaMissense 0.09
- R32P (p.Arg32Pro), rs746654539, gnomAD 2-127421307-G-C, REVEL 0.61, AlphaMissense 0.27
- R32R (p.Arg32Arg), gnomAD 2-127421308-T-C, CADD 5.02
- Q35R (p.Gln35Arg), rs1688076659, gnomAD 2-127421316-A-G, REVEL 0.30, AlphaMissense 0.09
- Q35H (p.Gln35His), rs754445822, gnomAD 2-127421317-G-C, REVEL 0.26, AlphaMissense 0.24
- V36M (p.Val36Met), gnomAD 2-127421318-G-A, REVEL 0.55, AlphaMissense 0.43
- V36L (p.Val36Leu), rs1318261693, gnomAD 2-127421318-G-T, REVEL 0.44, AlphaMissense 0.42
- V36V (p.Val36Val), gnomAD 2-127421320-G-A, CADD 5.75
- L37V (p.Leu37Val), rs780914969, gnomAD 2-127421321-C-G, REVEL 0.68, AlphaMissense 0.34
- L37P (p.Leu37Pro), rs748083494, gnomAD 2-127421322-T-C, REVEL 0.91, AlphaMissense 0.81
- L37L (p.Leu37Leu), gnomAD 2-127421323-G-A, CADD 1.27
- R38Q (p.Arg38Gln), rs773107370, ClinGen CA1859242, cosmic curated COSV52165, ClinVar RCV000984471, REVEL 0.53, AlphaMissense 0.12, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal recessive; Thrombophilia du
- R38W (p.Arg38Trp), rs769900251, ClinGen CA1859241, ClinVar RCV001727153, ClinVar RCV002543888, REVEL 0.78, AlphaMissense 0.19, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant; not provided
- I39I (p.Ile39Ile), rs1163991795, gnomAD 2-127421329-C-A, CADD 5.30
- R40C (p.Arg40Cys), rs199514227, ClinGen CA1859243, cosmic curated COSV52165, ClinVar RCV001347080, REVEL 0.63, AlphaMissense 0.32, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal recessive; Thrombophilia du
- R40H (p.Arg40His), rs770650361, gnomAD 2-127421331-G-A, REVEL 0.32, AlphaMissense 0.11
- R40L (p.Arg40Leu), gnomAD 2-127421331-G-T, REVEL 0.49, AlphaMissense 0.34
- R42C (p.Arg42Cys), rs774572099, ClinGen CA1859245, ClinVar RCV001200134, ClinVar RCV001379312, REVEL 0.85, AlphaMissense 0.89, Pathogenic/Likely pathogenic, Thrombophilia due to protein C deficiency, autosomal recessive; Thrombophilia du
- R42H (p.Arg42His), rs369504169, ClinGen CA211707, ClinVar RCV000148739, ClinVar RCV000851677, REVEL 0.93, AlphaMissense 0.43, Likely pathogenic, Deep venous thrombosis; Thromboembolism; Thrombophilia due to protein C deficien
- R42S (p.Arg42Ser), rs774572099, gnomAD 2-127421336-C-A, REVEL 0.84, AlphaMissense 0.92
- R42L (p.Arg42Leu), rs369504169, gnomAD 2-127421337-G-T, REVEL 0.94, AlphaMissense 0.76
- R42R (p.Arg42Arg), rs1459858777, gnomAD 2-127421338-T-A, CADD 0.28
- A43T (p.Ala43Thr), rs767626189, ClinGen CA1859246, ClinVar RCV001801321, ClinVar RCV003416461, REVEL 0.81, AlphaMissense 0.30, Conflicting interpretations, not specified; not provided; PROC-related disorder
- A43P (p.Ala43Pro), rs767626189, gnomAD 2-127421339-G-C, REVEL 0.81, AlphaMissense 0.63
- A43D (p.Ala43Asp), gnomAD 2-127421340-C-A, REVEL 0.72, AlphaMissense 0.56
- N44S (p.Asn44Ser), rs1416873800, gnomAD 2-127421343-A-G, REVEL 0.50, AlphaMissense 0.16
- N44N (p.Asn44Asn), rs775598456, gnomAD 2-127421344-C-T, CADD 5.71
- N44K (p.Asn44Lys), rs775598456, gnomAD 2-127421344-C-G, REVEL 0.51, AlphaMissense 0.79
- S45P (p.Ser45Pro), gnomAD 2-127421345-T-C, REVEL 0.52, AlphaMissense 0.62
- S45F (p.Ser45Phe), gnomAD 2-127421346-C-T, REVEL 0.45, AlphaMissense 0.39
- F46del (p.Phe46del), gnomAD 2-127421346-CCTT-, CADD 15.50
- F46L (p.Phe46Leu), rs141040323, gnomAD 2-127421350-C-G, REVEL 0.69, AlphaMissense 0.91
- F46F (p.Phe46Phe), rs141040323, gnomAD 2-127421350-C-T, CADD 6.66
- L47Q (p.Leu47Gln), cosmic curated COSV52164, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- L47V (p.Leu47Val), gnomAD 2-127421351-C-G, REVEL 0.59, AlphaMissense 0.27
- E48K (p.Glu48Lys), cosmic curated COSV10634, REVEL 0.91, AlphaMissense 0.72
- E48Q (p.Glu48Gln), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52168, Uncertain significance, Inborn genetic diseases
- L50del (p.Leu50del), gnomAD 2-127421359-GCTC-, CADD 15.80
- L50L (p.Leu50Leu), rs1455925750, gnomAD 2-127421362-C-T, CADD 1.00
- R51C (p.Arg51Cys), rs764546127, ClinGen CA1859249, NCI-TCGA Cosmic COSV5216, cosmic curated COSV52169, REVEL 0.68, AlphaMissense 0.39, Pathogenic/Likely pathogenic, Thrombophilia due to protein C deficiency, autosomal dominant; PROC-related diso
- R51S (p.Arg51Ser), rs764546127, gnomAD 2-127421363-C-A, REVEL 0.46, AlphaMissense 0.43
- R51H (p.Arg51His), rs1688080491, gnomAD 2-127421364-G-A, REVEL 0.64, AlphaMissense 0.12
- R51R (p.Arg51Arg), gnomAD 2-127421365-T-A, CADD 4.94
- H52T (p.His52Thr), rs1196026290, gnomAD 2-127421364-GT-G, CADD 15.80
- H52A (p.His52Ala), gnomAD 2-127421365-T-TG, CADD 18.70
- H52H (p.His52His), gnomAD 2-127421368-C-T, CADD 0.48
- S53G (p.Ser53Gly), gnomAD 2-127421369-A-G, REVEL 0.38, AlphaMissense 0.06
- S53R (p.Ser53Arg), gnomAD 2-127421370-GC-G, CADD 23.00
- S54I (p.Ser54Ile), cosmic curated COSV52168
- S54C (p.Ser54Cys), rs376049280, gnomAD 2-127421372-A-T, REVEL 0.76, AlphaMissense 0.44
- S54R (p.Ser54Arg), gnomAD 2-127421372-A-AGA, CADD 23.30
- S54N (p.Ser54Asn), gnomAD 2-127421373-G-A, REVEL 0.29, AlphaMissense 0.14
- S54S (p.Ser54Ser), rs1273141289, gnomAD 2-127421374-C-T, CADD 7.77
- L55P (p.Leu55Pro), rs2468325276, ClinGen CA348397935, ClinVar RCV002663929, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- L55M (p.Leu55Met), gnomAD 2-127421375-C-A, REVEL 0.63, AlphaMissense 0.15
- L55L (p.Leu55Leu), gnomAD 2-127421377-G-A, CADD 6.61
- E56Q (p.Glu56Gln), cosmic curated COSV52166, REVEL 0.89, AlphaMissense 0.16, Uncertain significance, Inborn genetic diseases
- E56A (p.Glu56Ala), gnomAD 2-127421376-TGG-T, CADD 27.50
- E56E (p.Glu56Glu), rs1558712080, gnomAD 2-127421380-G-A, CADD 5.02
- R57W (p.Arg57Trp), rs757583846, ClinGen CA334388, ClinVar RCV000168170, ClinVar RCV000490205, REVEL 0.90, AlphaMissense 0.48, Pathogenic/Likely pathogenic, Thrombophilia due to protein C deficiency, autosomal dominant; Thrombophilia due
- R57R (p.Arg57Arg), gnomAD 2-127421381-C-A, CADD 5.87
- R57L (p.Arg57Leu), rs574949343, gnomAD 2-127421382-G-T, REVEL 0.96, AlphaMissense 0.69
- R57Q (p.Arg57Gln), rs574949343, gnomAD 2-127421382-G-A, REVEL 0.92, AlphaMissense 0.25
- R57P (p.Arg57Pro), gnomAD 2-127421382-G-C, REVEL 0.96, AlphaMissense 0.96
- C59Y (p.Cys59Tyr), gnomAD 2-127421388-G-A, REVEL 0.95, AlphaMissense 0.96
- I60T (p.Ile60Thr), rs751218842, gnomAD 2-127421391-T-C, REVEL 0.40, AlphaMissense 0.08
- E61K (p.Glu61Lys), gnomAD 2-127421393-G-A, REVEL 0.90, AlphaMissense 0.71
- E62A (p.Glu62Ala), rs121918148, ClinGen CA114402, ClinVar RCV000000699, ClinVar RCV003398403, AlphaMissense 0.86, MetaLR 1.00, Pathogenic/Likely pathogenic, not provided; PROC-related disorder
- E62del (p.Glu62del), rs1223883395, gnomAD 2-127421392-AGAG-, CADD 20.80
- E62E (p.Glu62Glu), rs1276731365, gnomAD 2-127421398-G-A, CADD 10.70
- I63F (p.Ile63Phe), rs1438849881, gnomAD 2-127421399-A-T, REVEL 0.53, AlphaMissense 0.15
- I63N (p.Ile63Asn), rs1370099703, gnomAD 2-127421400-T-A, REVEL 0.42, AlphaMissense 0.12
- I63T (p.Ile63Thr), rs1370099703, gnomAD 2-127421400-T-C, REVEL 0.33, AlphaMissense 0.20
- D65N (p.Asp65Asn), rs1287265930, gnomAD 2-127421405-G-A, REVEL 0.35, AlphaMissense 0.16
- D65D (p.Asp65Asp), rs1034359374, gnomAD 2-127421407-C-T, CADD 8.75
- F66L (p.Phe66Leu), rs201463891, gnomAD 2-127421410-C-G, REVEL 0.36, AlphaMissense 0.88
- F66F (p.Phe66Phe), rs201463891, gnomAD 2-127421410-C-T, CADD 4.64
- E67D (p.Glu67Asp), cosmic curated COSV52164
- E67K (p.Glu67Lys), rs1448630830, ClinGen CA348398122, cosmic curated COSV99300, ClinVar RCV000761310, REVEL 0.89, AlphaMissense 0.52, Likely pathogenic, Thrombophilia due to protein C deficiency, autosomal dominant
- E68K (p.Glu68Lys), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52166, TOPMed rs1352609136, REVEL 0.92, AlphaMissense 0.72, Variant assessed as somatic; moderate impact.
- E68A (p.Glu68Ala), gnomAD 2-127421415-A-C, REVEL 0.88, AlphaMissense 0.81
- E68E (p.Glu68Glu), rs752294542, gnomAD 2-127421416-G-A, CADD 7.76
- A69V (p.Ala69Val), rs984698204, gnomAD 2-127421418-C-T, REVEL 0.66, AlphaMissense 0.57
- A69A (p.Ala69Ala), rs1688084116, gnomAD 2-127421419-C-A, CADD 11.40
- K70E (p.Lys70Glu), rs199469481, ClinGen CA55343075, ClinVar RCV003494637, UniProt VAR 074296, AlphaMissense 0.16, MetaLR 0.91, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- K70M (p.Lys70Met), cosmic curated COSV52168, ExAC rs568473236, TOPMed rs568473236, gnomAD rs568473236
- K70R (p.Lys70Arg), rs568473236, gnomAD 2-127421421-A-G, REVEL 0.35, AlphaMissense 0.07
- K70K (p.Lys70Lys), rs1573437416, gnomAD 2-127421422-G-A, CADD 8.79
- E71K (p.Glu71Lys), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52167, Variant assessed as somatic; moderate impact.
- E71D (p.Glu71Asp), rs1207902871, gnomAD 2-127421425-A-C, REVEL 0.89, AlphaMissense 0.76
- I72T (p.Ile72Thr), cosmic curated COSV99300, REVEL 0.95, AlphaMissense 0.87
- F73F (p.Phe73Phe), gnomAD 2-127421431-C-T, CADD 13.20
- Q74* (p.Gln74Ter), NCI-TCGA Cosmic COSV5216, cosmic curated COSV52164, NCI-TCGA Cosmic COSV9930, Variant assessed as somatic; high impact.
- Q74H (p.Gln74His), cosmic curated COSV99300
- Q74K (p.Gln74Lys), cosmic curated COSV99300
- V76M (p.Val76Met), rs121918149, ClinGen CA114404, ClinVar RCV000000700, ClinVar RCV000852081, REVEL 0.65, AlphaMissense 0.11, Pathogenic/Likely pathogenic, Abnormal thrombosis; Cerebral palsy
- V76G (p.Val76Gly), gnomAD 2-127421439-T-G, REVEL 0.50, AlphaMissense 0.15
- D77G (p.Asp77Gly), rs1688085227, gnomAD 2-127421442-A-G, REVEL 0.82, AlphaMissense 0.13
- D78N (p.Asp78Asn), rs749192814, gnomAD 2-127421444-G-A, REVEL 0.22, AlphaMissense 0.13
- T79R (p.Thr79Arg), rs2468325686, ClinGen CA348398210, ClinVar RCV003495031, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- T79T (p.Thr79Thr), gnomAD 2-127421449-A-C, CADD 13.50
- L80Q (p.Leu80Gln), cosmic curated COSV10723
- L80L (p.Leu80Leu), rs1433950308, gnomAD 2-127422917-C-T, CADD 19.40
- A81G (p.Ala81Gly), gnomAD 2-127422921-C-G, REVEL 0.46, AlphaMissense 0.14
- F82L (p.Phe82Leu), gnomAD 2-127422925-C-A, REVEL 0.89, AlphaMissense 0.97
- W83L (p.Trp83Leu), gnomAD 2-127422927-G-T, REVEL 0.80, AlphaMissense 0.74
- W83* (p.Trp83Ter), rs747236088, gnomAD 2-127422927-G-A, CADD 49.00
- S84P (p.Ser84Pro), rs1688199561, ClinGen CA348398653, ClinVar RCV003598528, AlphaMissense 0.14, MetaLR 0.88, Uncertain significance, Thrombophilia due to protein C deficiency, autosomal dominant
- S84A (p.Ser84Ala), gnomAD 2-127422929-T-G, REVEL 0.29, AlphaMissense 0.12
- S84Y (p.Ser84Tyr), gnomAD 2-127422930-C-A, REVEL 0.42, AlphaMissense 0.20
- S84S (p.Ser84Ser), gnomAD 2-127422931-C-G, CADD 15.10
- K85* (p.Lys85Ter), gnomAD 2-127422932-A-T, CADD 37.00
- K85T (p.Lys85Thr), rs768719609, gnomAD 2-127422933-A-C, REVEL 0.52, AlphaMissense 0.21
- K85R (p.Lys85Arg), rs768719609, gnomAD 2-127422933-A-G, REVEL 0.46, AlphaMissense 0.08
- H86H (p.His86His), gnomAD 2-127422937-C-T, CADD 16.80
- V87F (p.Val87Phe), gnomAD 2-127422938-G-T, REVEL 0.38, AlphaMissense 0.12
- V87I (p.Val87Ile), rs145854591, gnomAD 2-127422938-G-A, REVEL 0.29, AlphaMissense 0.10
- D88Y (p.Asp88Tyr), gnomAD 2-127422941-G-T, REVEL 0.88, AlphaMissense 0.65
- D88N (p.Asp88Asn), gnomAD 2-127422941-G-A, REVEL 0.69, AlphaMissense 0.50
- D88D (p.Asp88Asp), gnomAD 2-127423035-C-T, CADD 10.80
- D90D (p.Asp90Asp), rs1455500536, gnomAD 2-127423041-C-T, CADD 11.90
- Q91* (p.Gln91Ter), rs1408109998, gnomAD 2-127423042-C-T, CADD 39.00
- L93L (p.Leu93Leu), rs771415643, gnomAD 2-127423050-G-A, CADD 2.61
- L93F (p.Leu93Phe), rs771415643, gnomAD 2-127423050-G-T, REVEL 0.27, AlphaMissense 0.10
Public PROC analysis runs
- PROC analysis run — PROC (653 variants) — completed 2026-11-09
- PROC analysis run — PROC (880 variants) — completed 2026-08-19